# Pentoxifylline for Vascular Calcification in Kidney Disease

> **NCT06903689** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Mansoura University** · enrollment: 80 (estimated)

## Conditions studied

- Chronic Kidney Disease
- Vascular Calcification
- Kidney Failure, Chronic

## Interventions

- **DRUG:** Pentoxifylline 400 MG Oral Tablet
- **OTHER:** Conventional Medications for Chronic Kidney Disease

## Key facts

- **NCT ID:** NCT06903689
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-15
- **Primary completion:** 2025-10-15
- **Final completion:** 2025-10-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06903689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06903689, "Pentoxifylline for Vascular Calcification in Kidney Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06903689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*